Sign up to save your podcasts
Or
Share ACR2022 - Day 4.1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACR2022 - Day 4.1
Get the Skinny on Bimekizumab in PsA
Dr. Janet Pope discusses abstract presented at ACR22 Convergence in Philadelphia, PA.
L02: Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Results from a Phase 3, Randomized, Placebo-Controlled, Active Reference Study
Low dose steroids can negatively impact bone healthDr. Janet Pope discusses abstract L01 presented at ACR22 Convergence in Philadelphia, PA.
L01: Impact of Glucocorticoid Dosing and Anti-Osteoporotic Treatment on Bone Health in Patients with Inflammatory Rheumatic Musculoskeletal Diseases: A Longitudinal Cohort Study
The First Head to Head trial in Axial Spondyloarthritis
Dr. Lianne Gensler discusses abstract L15 presented at ACR22 Convergence in Philadelphia, PA.
L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis: A Randomized Phase IIIb Study
Why Clinical Trials?
Dr. Guillermo Valenzuela talks about the importance of clinical trials from ACR22 Convergence in Philadelphia, PA.
View all episodes
By Dr. Cush
4.7
121121 ratings
Get the Skinny on Bimekizumab in PsA
Dr. Janet Pope discusses abstract presented at ACR22 Convergence in Philadelphia, PA.
L02: Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Results from a Phase 3, Randomized, Placebo-Controlled, Active Reference Study
Low dose steroids can negatively impact bone healthDr. Janet Pope discusses abstract L01 presented at ACR22 Convergence in Philadelphia, PA.
L01: Impact of Glucocorticoid Dosing and Anti-Osteoporotic Treatment on Bone Health in Patients with Inflammatory Rheumatic Musculoskeletal Diseases: A Longitudinal Cohort Study
The First Head to Head trial in Axial Spondyloarthritis
Dr. Lianne Gensler discusses abstract L15 presented at ACR22 Convergence in Philadelphia, PA.
L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis: A Randomized Phase IIIb Study
Why Clinical Trials?
Dr. Guillermo Valenzuela talks about the importance of clinical trials from ACR22 Convergence in Philadelphia, PA.
More shows like Rheumnow Podcast
View all
AFP: American Family Physician Podcast
701 Listeners
JAMA Clinical Reviews
503 Listeners
Frankly Speaking About Family Medicine
263 Listeners
The Curbsiders Internal Medicine Podcast
3,381 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
The Evidence Based Rheumatology Podcast
115 Listeners
Healio Rheuminations
121 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
518 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
376 Listeners
ACR on Air
66 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
5 Listeners
Rheumatology For The Royal College
184 Listeners
ACR Journals On Air
20 Listeners
Talking Rheumatology Spotlight
6 Listeners